BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25808902)

  • 1. Molecular evolution of the CYP2D subfamily in primates: purifying selection on substrate recognition sites without the frequent or long-tract gene conversion.
    Yasukochi Y; Satta Y
    Genome Biol Evol; 2015 Mar; 7(4):1053-67. PubMed ID: 25808902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the CYP2D gene cluster in humans and four non-human primates.
    Yasukochi Y; Satta Y
    Genes Genet Syst; 2011; 86(2):109-16. PubMed ID: 21670550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of a first avian cytochrome P450 of the CYP2D subfamily (CYP2D49).
    Cai H; Jiang J; Yang Q; Chen Q; Deng Y
    PLoS One; 2012; 7(6):e38395. PubMed ID: 22675558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
    Kimura S; Umeno M; Skoda RC; Meyer UA; Gonzalez FJ
    Am J Hum Genet; 1989 Dec; 45(6):889-904. PubMed ID: 2574001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
    Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
    Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Non-Human Primate Cytochrome P450 2D Members and the Implication in Drug Discovery.
    He ZX; Chen XW; Yang Y; Zhou SF
    Curr Drug Metab; 2016; 17(6):520-7. PubMed ID: 26892731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of sites under adaptive evolution in cytochrome P450 sequences and their relationship to substrate recognition sites.
    Zawaira A; Matimba A; Masimirembwa C
    Pharmacogenet Genomics; 2008 Jun; 18(6):467-76. PubMed ID: 18496126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional and cellular distribution of CYP2D subfamily members in rat brain.
    Miksys S; Rao Y; Sellers EM; Kwan M; Mendis D; Tyndale RF
    Xenobiotica; 2000 Jun; 30(6):547-64. PubMed ID: 10923858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversifying selection detected in only a minority of xenobiotic-metabolizing
    Chaney ME; Romine MG; Piontkivska H; Tosi AJ
    Xenobiotica; 2020 Dec; 50(12):1406-1412. PubMed ID: 32558606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6.
    Heim MH; Meyer UA
    Genomics; 1992 Sep; 14(1):49-58. PubMed ID: 1358797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
    Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
    Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats.
    Matsunaga E; Zanger UM; Hardwick JP; Gelboin HV; Meyer UA; Gonzalez FJ
    Biochemistry; 1989 Sep; 28(18):7349-55. PubMed ID: 2819073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retained duplications and deletions of CYP2C genes among primates.
    Chaney ME; Piontkivska H; Tosi AJ
    Mol Phylogenet Evol; 2018 Aug; 125():204-212. PubMed ID: 29631055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic specificity of CYP2D isoforms in rat and human.
    Hiroi T; Chow T; Imaoka S; Funae Y
    Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.
    Johansson I; Lundqvist E; Bertilsson L; Dahl ML; Sjöqvist F; Ingelman-Sundberg M
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11825-9. PubMed ID: 7903454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A revised evolutionary history of the CYP1A subfamily: gene duplication, gene conversion, and positive selection.
    Goldstone HM; Stegeman JJ
    J Mol Evol; 2006 Jun; 62(6):708-17. PubMed ID: 16752211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative quantification of cytochrome P4502D6 and 2D7/8 pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain reaction.
    Endrizzi K; Fischer J; Klein K; Schwab M; Nüssler A; Neuhaus P; Eichelbaum M; Zanger UM
    Anal Biochem; 2002 Jan; 300(2):121-31. PubMed ID: 11779102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Tree Shrew Cytochrome P450 2Ds (CYP2D8a and CYP2D8b) Are Functional Drug-Metabolizing Enzymes that Metabolize Bufuralol and Dextromethorphan.
    Ushirozako G; Murayama N; Tsukiyama-Kohara K; Yamazaki H; Uno Y
    Drug Metab Dispos; 2024 Mar; 52(4):305-311. PubMed ID: 38262704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and expression of cytochrome P450 2D6 in the livers of domestic cats.
    Komatsu T; Honda K; Kubota A; Kitazawa T; Hiraga T; Teraoka H
    J Vet Med Sci; 2010 Dec; 72(12):1633-6. PubMed ID: 20661004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities.
    Venhorst J; ter Laak AM; Commandeur JN; Funae Y; Hiroi T; Vermeulen NP
    J Med Chem; 2003 Jan; 46(1):74-86. PubMed ID: 12502361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.